Gastrointestinal lymphoma

Gastrointestinal lymphoma is the most common form of cancer affecting cats and represents the most frequently diagnosed type of feline lymphoma overall. This malignant cancer originates in the lymphocytes, which are specialized white blood cells that form a critical component of the immune system. When these cells become cancerous within the gastrointestinal tract, they can infiltrate the stomach, small intestine, large intestine, and associated lymph nodes, disrupting normal digestive function and causing a range of serious health problems. Gastrointestinal lymphoma primarily affects senior cats, with most diagnoses occurring in cats over ten years of age, though it can occasionally develop in younger animals.

The underlying cause of gastrointestinal lymphoma involves the uncontrolled proliferation of abnormal lymphocytes within the digestive tract tissues. While the exact triggers remain incompletely understood, chronic inflammation of the gastrointestinal tract, particularly from conditions like inflammatory bowel disease, appears to increase the risk of lymphoma development. The transformation from normal lymphocytes to cancerous cells involves genetic mutations that allow the cells to divide without normal regulatory controls, eventually forming tumors or diffusely infiltrating the intestinal walls.

Gastrointestinal lymphoma significantly impacts a cat's overall health and quality of life by interfering with nutrient absorption, causing chronic digestive upset, and potentially spreading to other organs. Cats with this condition often experience progressive weight loss despite maintaining or even increasing their food intake, chronic vomiting or diarrhea, and a general decline in energy and wellbeing. The severity can range from relatively indolent low-grade forms that progress slowly over months to years, to aggressive high-grade lymphomas that can rapidly deteriorate a cat's health within weeks.

Despite its serious nature, gastrointestinal lymphoma is often treatable, particularly when diagnosed early and when the lymphoma is of the low-grade variety. Many cats respond well to chemotherapy protocols, which are generally well-tolerated compared to human cancer treatments. Early detection through regular veterinary examinations and prompt investigation of digestive symptoms can significantly improve outcomes. Working closely with a veterinarian or veterinary oncologist is essential for developing an appropriate treatment plan and monitoring response to therapy throughout the course of the disease.

The primary causes of gastrointestinal lymphoma in cats involve complex interactions between genetic factors, chronic inflammation, and immune system dysfunction. At the cellular level, lymphoma develops when lymphocytes acquire genetic mutations that disable normal growth control mechanisms, allowing these cells to proliferate unchecked. The specific mutations responsible for feline gastrointestinal lymphoma are still being researched, but they typically affect genes that regulate cell division, programmed cell death, and immune function. Unlike some other cancers, gastrointestinal lymphoma does not appear to have a single identifiable cause but rather develops through an accumulation of cellular damage over time.

While gastrointestinal lymphoma is not considered a directly inherited condition, certain genetic factors may predispose individual cats to developing this cancer. Some cats may have inherited variations in immune system genes that affect how their bodies regulate lymphocyte growth and respond to chronic inflammation. Additionally, cats with weakened immune systems, whether due to genetic factors or acquired conditions, may have reduced ability to eliminate abnormal cells before they become cancerous. Research has not identified specific breed-related genetic mutations associated with gastrointestinal lymphoma, suggesting that environmental and inflammatory factors play more significant roles than hereditary predisposition.

Environmental and lifestyle factors contribute to gastrointestinal lymphoma risk primarily through their effects on chronic inflammation and immune function. Cats with long-standing inflammatory bowel disease appear to have an elevated risk of developing intestinal lymphoma, suggesting that chronic immune activation in the gut creates conditions favorable for cancerous transformation. Dietary factors, exposure to environmental toxins, and chronic stress may all contribute to intestinal inflammation. Additionally, some studies have suggested potential links between feline leukemia virus or feline immunodeficiency virus infection and increased lymphoma risk, though many cats with gastrointestinal lymphoma have no history of these viral infections.

Age represents the most significant risk factor for gastrointestinal lymphoma, with the vast majority of cases occurring in cats over ten years old. The aging process itself contributes to cancer risk through accumulated DNA damage, declining immune surveillance, and cellular senescence. Older cats have had more time for potential carcinogenic exposures and for the gradual accumulation of genetic mutations necessary for cancer development. Cats with pre-existing gastrointestinal conditions, particularly chronic enteritis or inflammatory bowel disease, face increased risk regardless of age, as do cats with compromised immune function.

The mechanism by which gastrointestinal lymphoma develops typically involves a progression from normal lymphocyte function through various stages of abnormality. Initially, chronic inflammation in the intestinal tract causes repeated activation and proliferation of lymphocytes as part of the normal immune response. Over time, this constant stimulation increases the likelihood of genetic errors during cell division. When critical mutations occur in genes controlling cell growth, some lymphocytes escape normal regulatory controls and begin dividing independently. These cells gradually accumulate additional mutations, becoming increasingly abnormal and eventually forming lymphoma. This process explains why chronic inflammatory conditions like IBD are considered significant risk factors for lymphoma development.

Early warning signs of gastrointestinal lymphoma in cats are often subtle and easily overlooked, particularly given cats' natural tendency to hide signs of illness. The initial symptoms frequently mimic those of less serious digestive conditions, which can delay diagnosis. Owners may first notice their cat becoming slightly more selective about food or showing mild changes in appetite that seem unremarkable at first. Cats may begin to eat slightly less at each meal or show occasional disinterest in foods they previously enjoyed. These early changes often progress so gradually that owners may not recognize them as significant until looking back after diagnosis. Subtle weight loss, sometimes as little as a few ounces over several months, may occur before any obvious symptoms develop.

The most commonly observed symptoms of gastrointestinal lymphoma include chronic vomiting, diarrhea, weight loss, and decreased appetite. Vomiting may occur several times per week or even daily, and may contain bile, undigested food, or occasionally blood. The vomiting often appears unrelated to eating and may occur at any time. Diarrhea can range from soft stools to watery consistency and may be intermittent or persistent. Some cats develop alternating periods of diarrhea and constipation. Progressive weight loss despite maintaining reasonable food intake is particularly characteristic of gastrointestinal lymphoma, as the cancer interferes with nutrient absorption even when cats continue eating.

Behavioral changes associated with gastrointestinal lymphoma reflect the cat's declining health and chronic discomfort. Affected cats often become increasingly lethargic, spending more time sleeping and showing less interest in play or interaction with family members. Appetite changes are common, with some cats becoming finicky eaters while others may initially show increased hunger as their bodies struggle to absorb adequate nutrition. Cats may begin hiding more frequently, seeking out quiet, isolated spots rather than their usual resting places. Changes in litter box habits may include more frequent defecation, changes in stool consistency, or occasionally inappropriate elimination if the cat cannot reach the litter box in time.

Physical signs that owners or veterinarians may observe include visible weight loss with prominent spine and hip bones, a dull or unkempt coat due to reduced grooming, and pale gums indicating possible anemia. Some cats develop a noticeably distended abdomen due to thickened intestinal walls, enlarged lymph nodes, or fluid accumulation. Palpation of the abdomen may reveal thickened intestinal loops or masses, though this requires veterinary examination to assess properly. Muscle wasting, particularly over the spine and hindquarters, becomes increasingly apparent as the disease progresses and nutritional status declines.

Symptom progression in gastrointestinal lymphoma varies depending on whether the cat has low-grade or high-grade disease. Low-grade lymphoma typically progresses slowly over months to years, with symptoms gradually worsening but allowing extended periods of relatively stable health. Cats may experience episodic flare-ups interspersed with periods of apparent improvement. High-grade lymphoma progresses much more rapidly, with symptoms intensifying over weeks. Weight loss accelerates, vomiting and diarrhea become more frequent and severe, and cats may decline noticeably from week to week. The rate of deterioration often provides veterinarians with important prognostic information.

Emergency symptoms requiring immediate veterinary attention include severe, uncontrollable vomiting or diarrhea leading to dehydration, complete refusal to eat for more than 24-48 hours, extreme weakness or collapse, labored breathing, severely pale or white gums, and bloody vomit or stool. Cats showing signs of intestinal obstruction, such as repeated unproductive vomiting, severe abdominal pain, or complete cessation of bowel movements, need emergency evaluation. Any sudden, dramatic worsening of previously stable symptoms warrants urgent veterinary assessment, as does the development of new symptoms such as difficulty breathing or severe abdominal distension.

The diagnostic process for gastrointestinal lymphoma typically begins with a comprehensive veterinary examination and detailed history-taking. The veterinarian will ask about the duration and progression of symptoms, dietary history, previous health conditions, and any changes in behavior or appetite. During the physical examination, the veterinarian carefully palpates the abdomen to assess for thickened intestinal loops, masses, enlarged lymph nodes, or fluid accumulation. They will also evaluate the cat's body condition, hydration status, and check for other abnormalities such as pale gums suggesting anemia. This initial assessment helps determine which diagnostic tests are most appropriate and provides baseline information for monitoring treatment response.

Diagnostic testing for suspected gastrointestinal lymphoma typically includes comprehensive blood work, abdominal imaging, and ultimately tissue sampling. Blood tests including complete blood count, chemistry panel, and thyroid levels help assess overall health status, identify anemia, evaluate organ function, and rule out other conditions. Cats with gastrointestinal lymphoma may show low protein levels due to intestinal protein loss, low vitamin B12 levels indicating malabsorption, or elevated liver enzymes if the disease has spread. Abdominal ultrasound is particularly valuable for evaluating intestinal wall thickness, identifying enlarged lymph nodes, detecting masses, and guiding tissue sampling. Some cases may also require radiographs or advanced imaging such as CT scans.

Accurate diagnosis of gastrointestinal lymphoma requires differentiating it from other conditions that cause similar symptoms, particularly inflammatory bowel disease. This distinction is crucial because treatments differ significantly, yet the two conditions can appear remarkably similar on initial testing. Both IBD and lymphoma cause intestinal wall thickening, vomiting, diarrhea, and weight loss. Ultrasound findings may overlap between the conditions, though certain patterns suggest lymphoma over IBD. Other conditions requiring differentiation include intestinal parasites, food sensitivities, chronic pancreatitis, and other types of intestinal cancer. The only definitive way to distinguish lymphoma from IBD is through tissue biopsy and microscopic examination.

Definitive diagnosis of gastrointestinal lymphoma requires obtaining tissue samples for histopathological analysis. Tissue can be obtained through several methods, each with advantages and limitations. Fine needle aspirates collected via ultrasound guidance are minimally invasive but may not always provide enough tissue for definitive diagnosis. Endoscopic biopsies allow collection of tissue samples from the stomach and portions of the intestines without major surgery, though they only sample superficial layers and may miss lymphoma located deeper in the intestinal wall. Full-thickness surgical biopsies provide the most diagnostic tissue but require abdominal surgery. The pathologist examines the tissue microscopically to identify cancerous lymphocytes and determine whether the lymphoma is low-grade or high-grade, which significantly impacts treatment planning and prognosis.

Initial treatment for gastrointestinal lymphoma focuses on stabilizing the cat's condition and addressing immediate health concerns before beginning cancer-specific therapy. Cats presenting with severe symptoms may require hospitalization for intravenous fluid therapy to correct dehydration, anti-nausea medications to control vomiting, and nutritional support. Some cats may need appetite stimulants or temporary feeding tube placement if they have not been eating adequately. Blood transfusions may be necessary for severely anemic cats. Once the cat is stabilized, the veterinary team can proceed with developing a long-term treatment plan based on the type and extent of lymphoma, the cat's overall health status, and owner preferences regarding treatment intensity.

Chemotherapy represents the primary treatment for gastrointestinal lymphoma and is generally well-tolerated by cats compared to the side effects experienced by humans undergoing cancer treatment. For low-grade lymphoma, oral chemotherapy using chlorambucil combined with prednisolone forms the standard treatment protocol. This combination is administered at home, making it convenient for owners and less stressful for cats. The medications work to slow cancer cell growth and reduce inflammation in the intestinal tract. Treatment typically continues indefinitely, with regular monitoring to assess response and adjust dosages as needed. Many cats on this protocol maintain good quality of life for extended periods, often measured in years.

High-grade gastrointestinal lymphoma requires more aggressive chemotherapy, typically involving multi-drug injectable protocols administered at a veterinary clinic. Common protocols include CHOP-based regimens using cyclophosphamide, doxorubicin, vincristine, and prednisone, or variations thereof. Treatment usually involves weekly or biweekly veterinary visits for chemotherapy administration, with the intensive phase lasting several months followed by maintenance therapy. While high-grade lymphoma is more challenging to treat, some cats achieve complete remission with aggressive chemotherapy. The veterinary oncologist tailors the specific protocol to each cat's situation and monitors closely for response and potential side effects.

Supportive care plays an essential role in managing cats with gastrointestinal lymphoma throughout their treatment journey. Anti-nausea medications such as maropitant or ondansetron help control vomiting and improve appetite. Appetite stimulants like mirtazapine encourage eating in cats with poor food intake. Vitamin B12 supplementation addresses the deficiency that commonly develops due to intestinal malabsorption. Probiotics may help support intestinal health, and easily digestible prescription diets can improve nutrient absorption. Pain management, if needed, ensures the cat remains comfortable. Regular monitoring of weight and nutritional status guides adjustments to supportive care throughout treatment.

Complementary approaches may be considered alongside conventional treatment to support the cat's overall wellbeing. Acupuncture has shown some benefit for managing nausea and improving appetite in cancer patients. Nutritional supplements including omega-3 fatty acids may provide anti-inflammatory benefits. Some owners explore herbal supplements or traditional Chinese medicine under veterinary guidance, though evidence for their efficacy specifically in feline lymphoma is limited. Any complementary therapies should be discussed with the primary veterinarian or oncologist to ensure they do not interfere with conventional treatment or cause harmful interactions.

Treatment decisions involve balancing multiple factors including the type and stage of lymphoma, the cat's overall health and age, expected quality of life during treatment, treatment costs, and owner preferences. Low-grade lymphoma generally has an excellent response rate to oral chemotherapy, with many cats achieving remission or stable disease for years. High-grade lymphoma has a more guarded prognosis, though some cats respond well to aggressive treatment. Financial considerations are significant, as treatment costs accumulate over months to years of therapy. Veterinary oncologists help owners understand realistic expectations and make informed decisions aligned with their cat's best interests and family circumstances.

Recovery and remission timelines for gastrointestinal lymphoma vary substantially based on the type of lymphoma and individual response to treatment. Cats with low-grade lymphoma often show improvement within the first few weeks of starting oral chemotherapy, with reduced vomiting, improved appetite, and stabilization or regaining of weight. Remission in low-grade cases frequently occurs within one to two months of initiating treatment, and many cats maintain stable disease for years with continued therapy. High-grade lymphoma shows more variable response patterns, with some cats achieving remission within weeks while others prove more resistant to treatment. Initial response to chemotherapy is usually evident within the first few treatment cycles.

Post-treatment care for cats with gastrointestinal lymphoma involves ongoing medication administration, regular veterinary monitoring, and attention to nutrition and quality of life. For cats on oral chemotherapy protocols, owners administer medications at home following specific schedules and handling precautions for chemotherapy drugs. Regular recheck appointments, typically every few weeks initially and then monthly once stable, allow monitoring of blood counts, body weight, and overall condition. Periodic ultrasound examinations track intestinal changes and detect any progression. Owners should maintain detailed records of symptoms, appetite, weight, and any adverse effects to discuss at veterinary visits.

Prognosis for gastrointestinal lymphoma depends heavily on whether the disease is low-grade or high-grade. Low-grade gastrointestinal lymphoma carries a favorable prognosis, with median survival times typically ranging from two to three years, and some cats living significantly longer with continued treatment. Response rates to oral chemotherapy exceed 90 percent in many studies. High-grade lymphoma has a more guarded prognosis, with median survival times of several months even with aggressive treatment, though individual responses vary widely. Cats that achieve complete remission generally live longer than those with partial responses. Overall health status, early detection, and response to initial treatment all influence individual prognosis.

Long-term outlook for cats with gastrointestinal lymphoma requires accepting that this is typically a managed rather than cured condition. Most cats eventually experience disease progression despite treatment, though the timeline varies from months to years. Regular monitoring allows early detection of relapse, enabling treatment adjustments that may restore remission. Quality of life during treatment is generally good for most cats, particularly those with low-grade disease on oral protocols. Owners should work closely with their veterinary team to establish quality of life goals and criteria for evaluating whether continued treatment remains in the cat's best interest. End-of-life planning, while difficult to consider, helps ensure decisions are made thoughtfully when the time comes.

Primary prevention of gastrointestinal lymphoma presents significant challenges because the exact causes remain incompletely understood and no specific preventive measures have been proven to eliminate risk. However, maintaining overall health and minimizing factors associated with chronic intestinal inflammation may potentially reduce risk. Ensuring cats receive regular veterinary care allows early detection and treatment of digestive problems before they become chronic inflammatory conditions. Prompt investigation of persistent gastrointestinal symptoms such as chronic vomiting or diarrhea enables appropriate management that may reduce long-term intestinal inflammation. Keeping cats up to date on vaccinations against feline leukemia virus may help, as some studies suggest an association between viral infections and lymphoma risk.

Environmental factors that support intestinal health should be prioritized throughout a cat's life. Providing a stable, low-stress environment helps reduce stress-related gastrointestinal problems. Indoor housing protects cats from environmental toxins and reduces exposure to infectious diseases that might contribute to immune system dysfunction. Minimizing exposure to secondhand smoke, household chemicals, and pesticides eliminates potential carcinogens. Ensuring clean, fresh water is always available supports overall digestive health. These measures support general health even though their specific impact on lymphoma prevention remains unproven.

Dietary approaches to supporting gastrointestinal health may contribute to prevention, though no specific diet has been proven to prevent lymphoma. Feeding high-quality, easily digestible diets appropriate for the cat's life stage supports intestinal health. Some veterinarians recommend limited-ingredient or novel protein diets for cats with sensitive digestion. Avoiding frequent diet changes that might stress the digestive system makes sense for cats prone to gastrointestinal upset. Maintaining appropriate body weight through proper feeding reduces overall disease risk. Probiotic supplements may support healthy intestinal bacteria, though their role in cancer prevention is speculative.

Regular veterinary care forms the foundation of health maintenance and early disease detection. Annual or semi-annual wellness examinations allow veterinarians to detect subtle changes that might indicate developing problems. Regular blood work, particularly for senior cats, can identify early signs of disease before symptoms become apparent. Discussing any changes in appetite, digestion, weight, or behavior with the veterinarian ensures prompt investigation of potential problems. Building a long-term relationship with a veterinary practice provides continuity of care and better tracking of health trends over time.

Early intervention when gastrointestinal symptoms develop may reduce the risk of chronic inflammation progressing to more serious conditions. Any cat experiencing persistent vomiting, diarrhea, or unexplained weight loss should receive veterinary evaluation promptly rather than waiting to see if symptoms resolve. If inflammatory bowel disease is diagnosed, following treatment recommendations carefully and attending regular monitoring appointments helps control inflammation. Cats with IBD may benefit from more frequent veterinary surveillance given the association between chronic intestinal inflammation and lymphoma development. Working proactively with a veterinarian to optimize digestive health throughout a cat's life represents the best available strategy for supporting long-term intestinal health.

Daily management of a cat with gastrointestinal lymphoma centers on consistent medication administration, nutritional support, and quality of life optimization. Owners must adhere carefully to chemotherapy medication schedules, which typically involve giving oral pills at specific intervals. Proper handling precautions for chemotherapy drugs include wearing gloves when administering medications, disposing of waste appropriately, and washing hands thoroughly afterward. Keeping a medication log helps track doses and ensures consistency. Anti-nausea medications and appetite stimulants may need to be given at specific times relative to meals or other medications. Establishing a consistent daily routine reduces stress for both cat and owner.

Creating an optimal home environment supports the wellbeing of cats with gastrointestinal lymphoma. Providing easily accessible food and water stations, particularly for cats with reduced energy or mobility, ensures adequate nutrition and hydration. Litter boxes should be easily accessible and kept meticulously clean, as cats with digestive issues may need to eliminate more frequently or urgently. Comfortable resting spots in quiet areas allow cats to rest undisturbed when not feeling well. Maintaining a calm, stable household minimizes stress that might exacerbate symptoms. Climate control keeps cats comfortable, as temperature extremes can stress weakened immune systems.

Quality of life considerations should guide all management decisions throughout the course of treatment. Cats with well-managed lymphoma can enjoy many normal activities including gentle play, sunbathing, social interaction, and comfortable rest. Encouraging activities the cat enjoys, adjusted for energy levels, provides mental stimulation and maintains the human-animal bond. Monitoring for signs of contentment or distress helps gauge quality of life over time. Good days should be appreciated and enjoyed, while difficult days should prompt evaluation of whether adjustments to management might help. The goal is maximizing comfortable, enjoyable time while minimizing suffering.

Ongoing monitoring between veterinary visits helps identify changes requiring attention. Owners should track daily food intake, water consumption, litter box output, body weight (weekly weighing is helpful), and overall energy and demeanor. Keeping a simple diary or log makes it easy to identify trends and provides valuable information for veterinary visits. Any significant changes in symptoms, new symptoms, or concerns about medication side effects should prompt contact with the veterinary team. Learning to assess quality of life objectively, perhaps using a formal scale provided by the veterinarian, helps guide treatment decisions over time.

Caregiver support is essential for owners managing a cat's cancer diagnosis long-term. The emotional toll of caring for a seriously ill pet while maintaining normal responsibilities can be significant. Connecting with others who have experienced similar situations, whether through online support groups or local resources, provides valuable emotional support and practical advice. Having honest conversations with the veterinary team about realistic expectations and quality of life helps prepare for the future. Planning for end-of-life decisions in advance, while emotionally difficult, reduces stress when those decisions must be made. Financial planning for ongoing treatment costs helps reduce one source of stress. Self-care for caregivers, including respecting personal limits and seeking support when needed, enables sustained compassionate care for the cat throughout treatment.

Gastrointestinal lymphoma does not show strong breed predisposition in cats, occurring across all breeds and mixed-breed cats with relatively similar frequency. This cancer is primarily a disease of aging rather than genetics, with most cases occurring in cats over ten years of age regardless of breed background. Siamese cats have historically been reported to have slightly higher rates of lymphoma overall, including gastrointestinal forms, though this finding is not consistent across all studies. Some research suggests that Oriental breeds may have modestly elevated lymphoma risk compared to other breeds, but the increase is not dramatic enough to recommend breed-specific screening.

Mixed-breed domestic cats represent the largest population of cats diagnosed with gastrointestinal lymphoma, simply because they constitute the majority of the cat population. No particular mixed-breed types appear to be at higher risk than others. Among purebred cats, no breed shows sufficiently elevated risk to warrant specific preventive measures beyond those recommended for all cats. Age remains the most significant risk factor across all breeds, with cats over ten years facing substantially higher risk than younger cats. Cats with chronic gastrointestinal inflammation, regardless of breed, have elevated risk compared to cats without such history.

There are no specific genetic screening tests available for gastrointestinal lymphoma risk in cats, unlike some inherited conditions that can be identified through DNA testing. Screening recommendations focus on regular veterinary care and early investigation of gastrointestinal symptoms rather than breed-specific testing. All senior cats should receive regular wellness examinations, ideally every six months, to facilitate early detection of various age-related conditions including cancer. Owners of cats with chronic digestive problems should work with their veterinarians to monitor these cats closely given the association between chronic inflammation and lymphoma risk. Breeders do not currently screen for lymphoma predisposition, as no genetic markers have been identified for this purpose.

Inflammatory bowel disease represents the most significant condition related to gastrointestinal lymphoma, as chronic intestinal inflammation may progress to lymphoma over time. IBD and low-grade gastrointestinal lymphoma share many clinical features including chronic vomiting, diarrhea, weight loss, and intestinal wall thickening visible on ultrasound. Some researchers believe these conditions exist on a spectrum, with IBD representing a precancerous state that may transform to lymphoma in some cats. This relationship explains why definitive differentiation requires tissue biopsy and why cats with IBD should be monitored for potential progression. Management considerations overlap significantly, with dietary modification and anti-inflammatory approaches benefiting both conditions.

Conditions with symptoms similar to gastrointestinal lymphoma include other intestinal cancers such as mast cell tumors, adenocarcinoma, and other types of intestinal neoplasia. Chronic pancreatitis frequently causes vomiting, weight loss, and appetite changes similar to intestinal lymphoma. Hyperthyroidism in senior cats can cause weight loss despite good appetite, mimicking early lymphoma. Chronic kidney disease produces gradual weight loss and appetite changes. Intestinal parasites, food sensitivities, and foreign body ingestion can all cause persistent gastrointestinal symptoms. Accurate diagnosis through appropriate testing is essential because treatments differ substantially among these conditions, and delayed or incorrect treatment worsens outcomes.

Complications associated with gastrointestinal lymphoma include secondary conditions arising from the cancer itself or its treatment. Malnutrition from impaired intestinal absorption can lead to muscle wasting, weakened immune function, and delayed healing. Anemia may develop from chronic disease, intestinal blood loss, or bone marrow involvement. Chemotherapy can cause temporary immunosuppression, increasing infection risk. Some cats develop intestinal obstruction if masses block the intestinal passage. Spread of lymphoma to other organs including liver, spleen, and kidneys indicates disease progression and typically worsens prognosis. Close monitoring throughout treatment helps identify complications early, allowing appropriate intervention to maintain quality of life as long as possible.